Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Abraham P Zimelman, M.D.


Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Girnius SK, Lee S, Kambhampati S, Rose MG, Mohiuddin A, Houranieh A, Zimelman A, Grady T, Mehta P, Behler C, Hayes TG, Efebera YA, Prabhala RH, Han A, Yellapragada SV, Klein CE, Roodman GD, Lichtenstein A, Munshi NC. A Phase II trial of weekly bortezomib and dexamethasone in veterans with newly diagnosed multiple myeloma not eligible for or who deferred autologous stem cell transplantation. Br J Haematol. 2015 Apr; 169(1):36-43. PMID: 25572917.
    Citations: 4     Fields:    Translation:HumansCTClinical Trials
  2. Munshi NC, Lee S, Kambhampati S, Mohiuddin A, Rose MG, Behler C, Han A, Efebera YA, Houranieh A, Brophy MT, Zimelman A, Prabhala RH, Grady T, Klein CE, Mehta P, Hayes TG, Roodman GD, Lichtenstein A. Efficacy and improved toxicity profile of once a week bortezomib (BZ) with dexamethasone (dex) in newly diagnosed multiple myeloma (NDMM) patients (pts) with older age and comorbidities: Preliminary results of an ongoing clinical study. J Clin Oncol. 2011 May 20; 29(15_suppl):8074. PMID: 28023488.
  3. Najarian T, Miller A, Zimelman AP, Ki Hong W. Hematologic effects of cis-platinum-bleomycin therapy. Oncology. 1981; 38(4):195-7. PMID: 6165944.
    Citations:    Fields:    Translation:HumansCells
  4. McBrine PA, Miller A, Zimelman AP, Koff RS. Polycythemia vera with myelofibrosis and myeloid metaplasia. Acute hepatic failure following splenectomy. Am J Clin Pathol. 1980 Nov; 74(5):693-6. PMID: 7446477.
    Citations: 1     Fields:    Translation:Humans
  5. Zimelman AP, Miller A. Primary hemochromatosis with hereditary spherocytosis. Arch Intern Med. 1980 Jul; 140(7):983-4. PMID: 7387309.
    Citations: 4     Fields:    Translation:Humans
  6. Chopra S, Edelstein A, Koff RS, Zimelman AP, Lacson A, Neiman RS. Peliosis hepatis in hematologic disease. Report of two cases. JAMA. 1978 Sep 08; 240(11):1153-5. PMID: 682289.
    Citations: 5     Fields:    Translation:Humans
  7. Edelstein AD, Miller A, Zimelman AP, Rocklin RE, Neiman RS. Adult severe combined immunodeficiency and sarcoid-like granulomas with hypersplenism. Am J Hematol. 1978; 5(1):55-62. PMID: 371391.
    Citations: 1     Fields:    Translation:HumansCells
  8. Zimelman AP, Zimmerman HJ, McLean R, Weintraub LR. Effect of iron saturation of transferrin on hepatic iron uptake: an in vitro study. Gastroenterology. 1977 Jan; 72(1):129-31. PMID: 830225.
    Citations: 5     Fields:    Translation:Animals
  9. Miller A, Zimelman A, Brauer MJ. A family study of a patient with idiopathic hemochromatosis. Am J Hematol. 1977; 2(1):41-6. PMID: 868867.
    Citations:    Fields:    Translation:Humans
  10. Zimelman AP. Thrombocytosis in multiple myeloma. Ann Intern Med. 1973 Jun; 78(6):970-1. PMID: 4713579.
    Citations: 2     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Zimelman's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (56)
Co-Authors (3)
Similar People (60)
Same Department 
Physical Neighbors
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.